共 86 条
[1]
Carr A(2019)Success and failure of initial antiretroviral therapy in adults: an updated systematic review AIDS 33 443-453
[2]
Richardson R(2016)High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda? Infection 44 347-352
[3]
Liu Z(2019)Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016 Infection 47 247-255
[4]
Schäfer G(2018)Trends in antiretroviral therapy prescription, durability and modification: new drugs, more changes, but less failure AIDS 32 347-355
[5]
Kreuels B(2017)Increased persistence of initial treatment for hiv infection with modern antiretroviral therapy J Acquir Immune Defic Syndr 76 111-115
[6]
Schmiedel S(2018)Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort HIV Clinical Trials 19 52-60
[7]
Hertling S(2017)HIV-1 resistance rarely observed in patients using darunavir once-daily regimens across clinical studies HIV Clin Trials 18 196-204
[8]
Hüfner A(2016)HIV-1 drug resistance mutations emerging on darunavir therapy in PI naive and -experienced patients in the UK J Antimicrob Chemother 71 3487-3494
[9]
Degen O(2018)Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe HIV Med 19 324-338
[10]
van Lunzen J(2016)Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate Infection 44 641-649